Complicated Skin and Skin Structure Infection
📧 Sign up to get email alerts when something new happens for Complicated Skin and Skin Structure Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-01-27FDA Approved: ERTAPENEM — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for ertapenem submitted by Eugia US LLC, authorizing changes to its approved labeling and/or ind…
-
FDA approval · 2021-07-29FDA Approved: ZOSYN IN GALAXY CONTAINERS — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to allow Zosyn (piperacillin/tazobactam) to be supplied in Galaxy containers, by Wyeth Pharmaceutica…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) [Phase 3]
A Phase 3 trial evaluating PTK 0796 for complicated skin and skin structure infections was terminated, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) [Phase 2]
Phase 2 clinical trial evaluating PTK 0796 for complicated skin and skin structure infection has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting [Phase 4]
Phase 4 trial comparing Cubicin (daptomycin) with vancomycin in complicated skin and skin structure infections in a home infusion setting; s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients
Completed clinical trial comparing costs of linezolid versus vancomycin in patients with complicated skin and skin-structure infection and h…
-
FDA label_change · 2007-01-24FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for TYGACIL (tigecycline) submitted by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., to up…